197 related articles for article (PubMed ID: 36892933)
1. Interrogating the precancerous evolution of pathway dysfunction in lung squamous cell carcinoma using XTABLE.
Roberts M; Ogden J; Hossain ASM; Chaturvedi A; Kerr ARW; Dive C; Beane JE; Lopez-Garcia C
Elife; 2023 Mar; 12():. PubMed ID: 36892933
[TBL] [Abstract][Full Text] [Related]
2. Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression.
Ning B; Tilston-Lunel AM; Simonetti J; Hicks-Berthet J; Matschulat A; Pfefferkorn R; Spira A; Edwards M; Mazzilli S; Lenburg ME; Beane JE; Varelas X
J Exp Clin Cancer Res; 2023 May; 42(1):116. PubMed ID: 37150829
[TBL] [Abstract][Full Text] [Related]
3. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
Li Q; Hou J; Hu Z; Gu B; Shi Y
Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
5. Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression.
Beane J; Mazzilli SA; Tassinari AM; Liu G; Zhang X; Liu H; Buncio AD; Dhillon SS; Platero SJ; Lenburg ME; Reid ME; Lam S; Spira AE
Clin Cancer Res; 2017 Sep; 23(17):5091-5100. PubMed ID: 28533227
[No Abstract] [Full Text] [Related]
6. Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.
Lonergan KM; Chari R; Coe BP; Wilson IM; Tsao MS; Ng RT; Macaulay C; Lam S; Lam WL
PLoS One; 2010 Feb; 5(2):e9162. PubMed ID: 20161782
[TBL] [Abstract][Full Text] [Related]
7. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
8. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression Profiling Revealed 2 Types of Bronchial Basal Cell Hyperplasia and Squamous Metaplasia With Different Progression Potentials.
Denisov EV; Schegoleva AA; Gerashchenko TS; Skryabin NA; Sleptcov AA; Yakushina VD; Lyapunova LS; Tuzikov SA; Pankova OV; Perelmuter VM
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):477-483. PubMed ID: 30896548
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis.
Ooi AT; Gower AC; Zhang KX; Vick JL; Hong L; Nagao B; Wallace WD; Elashoff DA; Walser TC; Dubinett SM; Pellegrini M; Lenburg ME; Spira A; Gomperts BN
Cancer Prev Res (Phila); 2014 May; 7(5):487-95. PubMed ID: 24618292
[TBL] [Abstract][Full Text] [Related]
11. Minichromosome maintenance gene family: potential therapeutic targets and prognostic biomarkers for lung squamous cell carcinoma.
Yang X; Wang C; Nie H; Zhou J; He X; Ou C
Aging (Albany NY); 2022 Nov; 14(22):9167-9185. PubMed ID: 36445337
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions.
Beane JE; Mazzilli SA; Campbell JD; Duclos G; Krysan K; Moy C; Perdomo C; Schaffer M; Liu G; Zhang S; Liu H; Vick J; Dhillon SS; Platero SJ; Dubinett SM; Stevenson C; Reid ME; Lenburg ME; Spira AE
Nat Commun; 2019 Apr; 10(1):1856. PubMed ID: 31015447
[TBL] [Abstract][Full Text] [Related]
13. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
15. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
16. A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma.
Miao TW; Yang DQ; Chen FY; Zhu Q; Chen X
Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35866375
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
[TBL] [Abstract][Full Text] [Related]
18. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
[TBL] [Abstract][Full Text] [Related]
20. An integrative investigation on significant mutations and their down-stream pathways in lung squamous cell carcinoma reveals CUL3/KEAP1/NRF2 relevant subtypes.
Liu Z; Deng M; Wu L; Zhang S
Mol Med; 2020 May; 26(1):48. PubMed ID: 32434476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
